BRIEF-Otsuka, Lundbeck's Abilify Maintena approved in EU

COPENHAGEN Thu Nov 21, 2013 2:16am EST

Related Topics

COPENHAGEN Nov 21 (Reuters) - Danish pharmaceutical company H. Lundbeck A/S said on Thursday: * Once-monthly Abilify Maintena, which is developed in partnership with Japan's Otsuka , has been approved by the European Commision for maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.